tirzepatide vs glp 1 for weight loss vs. Semaglutide: Which GLP-1 Better Preserves Muscle? [SURMOUNT-5 Data] Semaglutide & Tirzepatide Weight Loss

For context, most telehealth providers in this space hover between 3.5 and 4.5 stars

Tirzepatide (Mounjaro, Zepbound) Tirzepatide targets both GLP-1 and GIP receptors, producing greater average weight loss than semaglutide in head-to-head trials, typically 20 to 25 percent of body weight

Combining agents with overlapping metabolic targets raises questions about additive versus synergistic effects, and whether the benefit-to-risk ratio improves or worsens with dual use

In summary, FOXO4-DRI exerts its anti-aging effects by inhibiting the binding of FOXO4 to P53, promoting P53 phosphorylation, and facilitating the translocation of p-P53 from the nucleus to the cytoplasm for its functional role

A., Bruynooghe, Y., Beyaert, R

GIP also signals the body to release more insulin when glucose levels are high